Jonathan Krell

5.2k total citations
126 papers, 2.6k citations indexed

About

Jonathan Krell is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jonathan Krell has authored 126 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 51 papers in Cancer Research and 44 papers in Molecular Biology. Recurrent topics in Jonathan Krell's work include MicroRNA in disease regulation (26 papers), Ovarian cancer diagnosis and treatment (20 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Jonathan Krell is often cited by papers focused on MicroRNA in disease regulation (26 papers), Ovarian cancer diagnosis and treatment (20 papers) and Pancreatic and Hepatic Oncology Research (14 papers). Jonathan Krell collaborates with scholars based in United Kingdom, Italy and United States. Jonathan Krell's co-authors include Justin Stebbing, Adam E. Frampton, Leandro Castellano, Long R. Jiao, Loredana Pellegrino, Jimmy Jacob, Victoria Harding, Mark P. Lythgoe, Elisa Giovannetti and R. Charles Coombes and has published in prestigious journals such as The Lancet, Nucleic Acids Research and Nature Communications.

In The Last Decade

Jonathan Krell

123 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Krell United Kingdom 29 1.4k 1.3k 814 278 257 126 2.6k
Ilse Van der Auwera Belgium 28 1.4k 1.0× 1.1k 0.8× 1.3k 1.6× 292 1.1× 224 0.9× 49 2.7k
Dorina Belotti Italy 26 1.3k 0.9× 779 0.6× 897 1.1× 220 0.8× 182 0.7× 43 2.4k
Germana Castelli Italy 29 1.6k 1.2× 950 0.7× 798 1.0× 478 1.7× 228 0.9× 97 3.1k
Peixin Dong Japan 35 2.4k 1.7× 1.8k 1.4× 942 1.2× 260 0.9× 132 0.5× 72 3.4k
Lenka Radová Czechia 30 1.7k 1.2× 1.5k 1.1× 441 0.5× 373 1.3× 233 0.9× 135 2.7k
Rafał Matkowski Poland 28 865 0.6× 696 0.5× 1.2k 1.5× 316 1.1× 184 0.7× 183 2.3k
Rudolf Nenutil Czechia 24 1.7k 1.2× 919 0.7× 895 1.1× 215 0.8× 199 0.8× 100 2.6k
Joseph Kwong Hong Kong 32 1.6k 1.2× 757 0.6× 803 1.0× 241 0.9× 169 0.7× 56 2.8k
Suki Kang South Korea 27 1.2k 0.8× 666 0.5× 879 1.1× 222 0.8× 171 0.7× 54 2.1k
Daniele Fanale Italy 29 1.2k 0.9× 922 0.7× 979 1.2× 437 1.6× 161 0.6× 84 2.5k

Countries citing papers authored by Jonathan Krell

Since Specialization
Citations

This map shows the geographic impact of Jonathan Krell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Krell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Krell more than expected).

Fields of papers citing papers by Jonathan Krell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Krell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Krell. The network helps show where Jonathan Krell may publish in the future.

Co-authorship network of co-authors of Jonathan Krell

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Krell. A scholar is included among the top collaborators of Jonathan Krell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Krell. Jonathan Krell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ennis, Darren, Bingxin Lu, Hasan Mirza, et al.. (2024). The genomic trajectory of ovarian high‐grade serous carcinoma can be observed in STIC lesions. The Journal of Pathology. 264(1). 42–54. 6 indexed citations
3.
Xing, Eric P., et al.. (2024). 1591P Development and economic trends in new anticancer therapies licensed in the UK from 2020 to 2024. Annals of Oncology. 35. S958–S959. 1 indexed citations
4.
Krell, Jonathan, John McGrane, Andreas D. Hartkopf, et al.. (2024). Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progression. Future Oncology. 20(40). 3409–3419. 1 indexed citations
5.
Liu, Daniel, Mireia Mato Prado, Elisa Giovannetti, et al.. (2023). MOY 2 MicroRNAs as Bile Based Biomarkers for Pancreaticobiliary Cancers (MIRABILE). British journal of surgery. 110(Supplement_6). 1 indexed citations
6.
Frost, Susan C., Chiara Moriconi, Tracy Perry, et al.. (2023). 2271P Development of an oncolytic virus for the treatment of high grade serous ovarian cancer and other stromal rich tumours. Annals of Oncology. 34. S1166–S1166. 2 indexed citations
7.
Merali, Nabeel, Daniel Liu, Tony Dhillon, et al.. (2023). Bile Microbiome Signatures Associated with Pancreatic Ductal Adenocarcinoma Compared to Benign Disease: A UK Pilot Study. International Journal of Molecular Sciences. 24(23). 16888–16888. 5 indexed citations
8.
Banerjee, Susana, Gaia Giannone, Andrew R. Clamp, et al.. (2023). Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma. JAMA Oncology. 9(5). 675–675. 13 indexed citations
9.
Cunnea, Paula, Edward Curry, Elizabeth L. Christie, et al.. (2023). Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes. Cell Reports Medicine. 4(6). 101055–101055. 19 indexed citations
10.
Krell, Jonathan, John McGrane, Anjana Anand, et al.. (2022). 2022-RA-1505-ESGO Ovarian cancer retrospective European (O’CaRE) observational study: analysis of first-line (1L) outcomes in patients with ovarian cancer (OC) stratified by number of risk factors for progression. International Journal of Gynecological Cancer. 32. A344–A344. 1 indexed citations
11.
Liu, Daniel, et al.. (2022). The Clinical Significance of Transfer RNAs Present in Extracellular Vesicles. International Journal of Molecular Sciences. 23(7). 3692–3692. 9 indexed citations
12.
Mirza, Hasan, Darren Ennis, Philip Smith, et al.. (2022). The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma. Clinical Cancer Research. 28(13). 2911–2922. 28 indexed citations
13.
Ottaviani, Silvia, et al.. (2022). How does the polymer architecture and position of cationic charges affect cell viability?. Polymer Chemistry. 14(3). 303–317. 14 indexed citations
14.
Constantinou, Anna P., Valeria Nele, James Doutch, et al.. (2022). Investigation of the Thermogelation of a Promising Biocompatible ABC Triblock Terpolymer and Its Comparison with Pluronic F127. Macromolecules. 55(5). 1783–1799. 22 indexed citations
15.
Lythgoe, Mark P., Daniel Liu, Nicola Annels, Jonathan Krell, & Adam E. Frampton. (2021). Gene of the month: lymphocyte-activation gene 3 (LAG-3). Journal of Clinical Pathology. 74(9). 543–547. 31 indexed citations
16.
Limb, Christopher, Daniel Liu, Morten T. Venø, et al.. (2020). The Role of Circular RNAs in Pancreatic Ductal Adenocarcinoma and Biliary-Tract Cancers. Cancers. 12(11). 3250–3250. 22 indexed citations
17.
Krell, Jonathan, Justin Stebbing, Claudia Carissimi, et al.. (2015). TP53 regulates miRNA association with AGO2 to remodel the miRNA–mRNA interaction network. Genome Research. 26(3). 331–341. 43 indexed citations
18.
Alshaker, Heba, Jonathan Krell, Adam E. Frampton, et al.. (2014). Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway. Breast Cancer Research. 16(5). 426–426. 42 indexed citations
19.
Pinho, Filipa G., Adam E. Frampton, João Nunes, et al.. (2013). Downregulation of microRNA-515-5p by the Estrogen Receptor Modulates Sphingosine Kinase 1 and Breast Cancer Cell Proliferation. Cancer Research. 73(19). 5936–5948. 67 indexed citations
20.
Zabron, Abigail, et al.. (2013). OC-038 Specific Microrna Markers are Identified in Bile in Pancreatic Ductal Adenocarcinoma. Gut. 62(Suppl 1). A17.2–A18. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilse Van der Auwera Breakdown of academic impact, for papers by Dorina Belotti Breakdown of academic impact, for papers by Germana Castelli Breakdown of academic impact, for papers by Peixin Dong Breakdown of academic impact, for papers by Lenka Radová Breakdown of academic impact, for papers by Rafał Matkowski Breakdown of academic impact, for papers by Rudolf Nenutil Breakdown of academic impact, for papers by Joseph Kwong Breakdown of academic impact, for papers by Suki Kang Breakdown of academic impact, for papers by Daniele Fanale
Rankless by CCL
2026